Probiotics and prevention of necrotizing enterocolitis

Early Human Development

Volumn 85, Issue 10 SUPPL., 2009, Pages

  Mshvildadze, Maka ^a,b   Neu, Josef ^b  

^a Chachava Scientific Research Institute of Perinatal Medicine Obstetrics and Gynecology   (Georgia)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Microbiome; Microbiota; Necrotizing enterocolitis; Prebiotics intestine; Premature infant; Probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

DOUBLE BLIND PROCEDURE; HUMAN; INCIDENCE; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DOUBLE-BLIND METHOD; ENTEROCOLITIS, NECROTIZING; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; PREBIOTICS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 76249111898     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2009.08.021     Document Type: Article

References (48)

1. Caplan M.S. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis. J Perinatol 2009, 29:S2-S6.
2. Hintz S.R., Kendrick D.E., Stoll B.J., Vohr BR., Fanaroff AA., Donovan EF., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005, 115(3):696-703.
3. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996, 43(2):409-432.
4. Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr Suppl 2005, 94(449):100-105.
5. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368(9543):1271-1283.
6. Grave G.D., Nelson S.A., Walker W.A., Moss R.L., Dvorak B., Hamilton F.A., et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007, 62(4):510-514.
7. Alfaleh K., Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008, 23(1):CD005496.
8. Barclay A.R., Stenson B., Simpson J.H., Weaver L.T., Wilson D.C. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007, 45(5):569-576.
9. Deshpande G., Rao S., Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007, 369(9573):1614-1620.
10. Martin C.R., Walker W.A. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008, 32(2):127-137.
11. Boyle R.J., Robins-Browne R.M., Tang M.L. Probiotic use in clinical practice: what are the risks?. Am J Clin Nutr 2006, 83(6):1256-1264.
12. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 2007, 65(6Pt.1):282-285.
13. Dani C., Biadaioli R., Bertini G., Martelli E., Rubaltelli F.F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002, 82(2):103-108.
14. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999, 3:197-202.
15. Lin H.C., Su B.H., Chen A.C., Lin T.W., Tsai C.H., Yeh T.F., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005, 115(1):1-4.
16. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005, 147(2):192-196.
17. Lin H.C., Hsu C.H., Chen H.L., Chung M.Y., Hsu J.F., Lien R.I., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122(4):693-700.
18. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136(1):65-80.
19. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(2):229-241.
20. Madara J. Building an intestine-architectural contributions of commensal bacteria. N Engl J Med 2004, 351(16):1685-1686.
21. Neish A.S. The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 2002, 4(3):309-317.
22. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289(5484):1560-1563.
23. Claud E.C., Lu L., Anton P.M., Savidge T., Walker W.A., Cherayil B.J. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci U S A 2004, 101(19):7404-7408.
24. Zhang L., Li N., Caicedo R., Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-{alpha}-induced interleukin-8 production in Caco-2 cells. J Nutr 2005, 135(7):1752-1756.
25. Liong M.T. Safety of probiotics: translocation and infection. Nutr Rev 2008, 66(4):192-202.
26. Huurre A., Kalliomäki M., Rautava S., Rinne M., Salminen S., Isolauri E. Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology 2008, 93(4):236-240.
27. Palmer C., Bik E.M., Digiulio D.B., et al. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5(7):e177.
28. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for treating eczema. Cochrane Database Syst Rev 2008, (4):CD006135.
29. Kopp E.B., Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995, 58:1-27.
30. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 2007, 65(6 Pt1):282-285.
31. Kalliomaki M., Salminen S., Poussa T., Isolauri E. Probiotics during the first 7years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(4):1019-1021.
32. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121(4):e850-e856.
33. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007, 119(1):184-191.
34. Hamer H.M., Jonkers D., Venema K., et al. The role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27(2):104-119.
35. Peng L., He Z., Chen W., Holzman I.R., Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 2007, 61(1):37-41.
36. Lopez M., Li N., Kataria J., Russell M., Neu J. Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. J Nutr 2008, 138(11):2264-2268.
37. Shibolet O., Podolsky D.K. TLRs in the gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol 2007, 292(6):G1469-G1473.
38. Barrat E., Michel C., Poupeau G., et al. Supplementation with galactooligosaccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatr Res 2008, 64(1):34-39.
39. Caplan M.C. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis. J Perinatol 2009, 29:S2-S6. 10.1038/jp.2009.21.
40. Boehm G., Stahl B. Oligosaccharides. Functional dairy products 2003, 203-243. Woodhead Publishing, Cambridge. T. Mattila-Sandholm (Ed.).
41. Schumacher G., Bendas G., Stahl B., Beermann C. Human milk oligosaccharides affect P-selectin binding capacities: in vitro investigation. Nutrition 2006, 22(6):620-627.
42. Srinivasjois R., Rao S., Patole S. Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomised controlled trials. Clin Nutr June 2009, 28(3):237-242.
43. Kapiki A., Costalos C., Oikonomidou C., Triantafyllidou A., Loukatou E., Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev 2007, 83(5):335-339.
44. Indrio F., Riezzo G., Montagna O., Valenzano E., Mautone A., Boehm G. J Pediatr Gastroenterol Nutr 2007, e122.
45. Mihatsch W.A., Hoegel J., Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr 2006, 95(7):843-848.
46. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002, 86(3):F178-F181.
47. Park J., Floch M.H. Prebiotics, probiotics, and dietary fiber in gastrointestinal disease. Gastroenterol Clin North Am 2007, 36:47-63.
48. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology January 2009, 136(1):65-80.